InvestorsHub Logo
Followers 239
Posts 12039
Boards Moderated 0
Alias Born 08/14/2003

Re: ilovetech post# 672864

Saturday, 02/17/2024 8:26:16 PM

Saturday, February 17, 2024 8:26:16 PM

Post# of 688825
I'll be the first to admit, I like to play devil's advocate to get people thinking of other possibilities, but what bashers are doing is baiting people to discuss issues that most everyone knowledgeable agree have been settled ages ago.

Some of our bashers would have us believing the BLA is DOA because changes were made during the trial. It doesn't matter to them that the regulators were involved in the changes, it's why they say it's a failure. We know better, but while it may not have been discussed for months or years, they make a statement and restart the debate.

No trial is an absolute certainty, but to me it would be a crime if any of the regulators substantially delay it's approval. We all know that DCVax-L will do much better when combined with other therapeutics, but that's no reason not to approve a product that more than doubled life expectancy at 5 years. Most cancer products can be approved if a 10% survival improvement is proven, we did roughly 160%.

Gary
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News